Effect of complement fragment 1 esterase inhibition on survival of human Decay-Accelerating factor pig lungs perfused with human blood

Journal of Heart and Lung Transplantation

Volumn 22, Issue 12, 2003, Pages 1365-1375

  Schröder, Carsten ^a   Pfeiffer, Steffen ^a   Wu, Guosheng ^a   Zorn III, George L ^a,b   Ding, Li ^a   Allen, Catherine ^b   Harrison, Richard A ^c   White, David J G ^c   Azimzadeh, Agnes M ^a,b   Pierson III, Richard N ^a,b,d  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Imutran Limited   (United Kingdom)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERINERT P; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; EVALUATION; HUMAN; HYPERACUTE GRAFT REJECTION; ISOLATED LUNG; LUNG PERFUSION; LUNG SEQUESTRATION; LUNG VASCULAR RESISTANCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; SWINE; THROMBOCYTE;

EID: 10744231051     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00026-3     Document Type: Article

References (31)

1. Miyatke T, Sato K, Takigami, et al. Complement-fixing elicited antibodies are major in the pathogenesis of xenograft rejection. J Immunol 1998;160:4114.
2. Platt J.L., Fischel R.J., Matas A.J., Reif S.A., Bolman R.M., Bach F.H. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation. 52:1991;214.
3. Dalmasso A.P., Vercellotti G.M., Fischel R.J., Bolman R.M., Bach F.H., Platt J.L. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol. 140:1992;1157.
4. Platt J.L., Saadi S. The role of complement in transplantation. Mol Immunol. 36:1999;965.
5. Levy L., Lepow I. Assay and properties of serum inhibitor of C1 esterase. Proc Soc Exp Biol Med. 101:1959;608-611.
6. Harpel P.C., Cooper N.R. Studies on human plasma C1-inactivator-enzyme interactions I. Mechanisms of interaction with C1s, plasmin and trypsin. J Clin Invest. 55:1975;593-604.
7. 2 complex from immobilized human IgG subclasses. Clin Immunol Immunopathol. 87:1998;68-74.
8. Ziccardi R.J. Demonstration of the interaction of native C1 with monomeric immunoglobulins and C1 inhibitor. J Immunol. 134:1985;2559-2563.
9. Gigli I., Mason J.W., Colman R.W., Austen K.F. Interaction of plasma kallikrein with the C1 inhibitor. J Immunol. 104:1970;574-581.
10. Wuillemin W.A., Minnema M., Meijers J.C. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes major role of C1-inhibitor . Blood. 85:1995;1517-1526.
11. Schreiber A.D., Kaplan A.P., Austen K.F. Inhibition by C1-INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest. 52:1973;1402-1409.
12. Matsushita M., Thiel S., Jensenuis J.C., Terai I., Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol. 165:2000;2537-2542.
13. Cozzi E., White D.J.G. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1:1995;964.
14. Ryan U.S. Complement inhibitory therapeutics and xenotransplantation. Nature Med. 1:1995;967.
15. Mollnes T.E., Fiane A.E. Xenotransplantation how to overcome the complement obstacle . Mol Immunol. 36:1999;269.
16. Leventhal J.R., Dalmasso A.P., Cromwell J.W., et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation. 55:1993;857.
17. Azimzadeh A, Zorn GL III, Blair KSA, et al. Hyperacute lung rejection in the pig-to-human model. Synergy between soluble and membrane complement inhibition. Xenotransplantation 2003;10:120-31.
18. Fiane A.E., Videm V., Johansen H.T., Mellbye O.J., Nielsen E.W., Mollnes T.E. C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model. Immunopharmacology. 42:1999;231-243.
19. Hecker J.M., Lorenz R., Appiah R., et al. C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplant. Transplantation. 73:2002;688-694.
20. Blum M.G., Collins B.J., Chang A.C., Zhang J.P., Knaus S.A., Pierson R.N. III. Complement inhibition by FUT-175 and K76-COOH in a pig-to-human lung xenotransplant model. Xenotransplantation. 5:1998;35-43.
21. Collins B.J., Blum M.G., Parker R.E., et al. Thromboxane mediates pulmonary hypertension and contributes to lung inflammation during hyperacute lung rejection. J Appl Physiol. 90:2001;2257-2268.
22. Zhang J.P., Blum M.G., Chang A.C., et al. Immunohistologic evaluation of mechanisms mediating hyperacute lung rejection, and the effect of treatment with K76-COOH, FUT-175, and anti-Gal column immunoadsorption. Xenotransplantation. 6:1999;249-261.
23. Rieben R., Von Allmen E., Korchagina E.Y., et al. Detection, immunoabsorption, and inhibition of cytotoxic activity of anti-aGal antibodies using newly developed substances with synthetic Gal α1-3Gal disaccharide epitopes. Xeno. 2:1995;98-106.
24. Pfeiffer S., Zorn G.L., Kelishadi S., et al. Role of anti-Galα1, 3Gal and anti-platelet antibodies in hyperacute rejection of pig lung by human blood. Ann Thorac Surg. 72:2001;1681-1690.
25. Fiane A.E., Mollnes T.E., Videm V., et al. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation. 6:1999;52-65.
26. Jakobs F.M., Davis E.A., White T., Sanfilippo F., Baldwin W.M. III. Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients. J Heart Lung Transplant. 17:1998;306-311.
27. Kaplan A.P., Joseph K., Shibayama Y., Reddigari S., Ghebrehiwet B., Silverberg M. The intrinsic coagulation/kinin-forming cascade assembly in plasma and cell surfaces in inflammation . Adv Immunol. 66:1997;225-272.
28. 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med. 178:1993;579-587.
29. Lau C.L., Daggett W.C., Yeatman M.F., et al. The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. J Thorac Cardiovasc Surg. 120:2000;29.
30. Macchiarini P., Oriol R., Azimzadeh A., et al. Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion. J Thorac Cardiovasc Surg. 116:1998;831.
31. Daggett C.W., Yeatman M., Lodge A.J., et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg. 115:1998;19.